SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001739614-22-000061
Filing Date
2022-05-26
Accepted
2022-05-26 16:31:04
Documents
1
Period of Report
2022-05-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_165359702607100.html 4  
1 FORM 4 wf-form4_165359702607100.xml 4 3979
  Complete submission text file 0001739614-22-000061.txt   5393
Mailing Address C/O HERON THERAPEUTICS, INC 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address
MANHARD KIMBERLY (Reporting) CIK: 0001202094 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39452 | Film No.: 22970588

Mailing Address 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037
Business Address 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037 (858) 795-4220
Inhibrx, Inc. (Issuer) CIK: 0001739614 (see all company filings)

IRS No.: 824257312 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)